JP Morgan Chase’s Opko Health OPK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-2,700
Closed -$3K 7092
2022
Q4
$3K Hold
2,700
﹤0.01% 6257
2022
Q3
$5K Buy
2,700
+2,000
+286% +$4.73K ﹤0.01% 6098
2022
Q2
$2K Hold
700
﹤0.01% 6291
2022
Q1
$2K Sell
700
-50,600
-99% -$179K ﹤0.01% 6431
2021
Q4
$247K Hold
51,300
﹤0.01% 5231
2021
Q3
$187K Hold
51,300
﹤0.01% 5270
2021
Q2
$208K Hold
51,300
﹤0.01% 5230
2021
Q1
$220K Buy
51,300
+12,500
+32% +$59.7K ﹤0.01% 5111
2020
Q4
$153K Buy
+38,800
New +$162K ﹤0.01% 4892
2019
Q1
Sell
-250,000
Closed -$753K 5957
2018
Q4
$753K Hold
250,000
﹤0.01% 3906
2018
Q3
$865K Hold
250,000
﹤0.01% 4003
2018
Q2
$1.18M Hold
250,000
﹤0.01% 3736
2018
Q1
$793K Sell
250,000
-115,000
-32% -$463K ﹤0.01% 3805
2017
Q4
$1.79M Hold
365,000
﹤0.01% 3386
2017
Q3
$2.53M Buy
+365,000
New +$2.3M ﹤0.01% 3020

Other funds holding OPK

JP Morgan Chase's OPK Position: Q1 2026 in Review

JP Morgan Chase reduced its Opko Health (OPK) stake by 12% in Q1 2026, selling an estimated $87.8K and leaving 508,484 shares worth $559K. The position accounts for ﹤0.01% of the portfolio, ranked #4924.

JP Morgan Chase first reported a position in OPK in Q2 2013 and has held it in 45 quarters since. The position peaked at $10.6M in Q4 2021. 235 funds tracked by Wall St. Rank hold OPK as of Q1 2026.

  • JP Morgan Chase held 508,484 shares of Opko Health worth $559K as of Q1 2026.
  • JP Morgan Chase sold 71,294 Opko Health shares in Q1 2026, an estimated $87.8K.
  • Opko Health made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #4924 holding.
  • JP Morgan Chase first reported a position in Opko Health in Q2 2013 and has held it in 45 quarters since.
  • JP Morgan Chase's Opko Health position peaked at $10.6M in Q4 2021.
  • 235 funds tracked by Wall St. Rank held Opko Health as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.